Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0DBJXG
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
BCG033
|
|||||
| Synonyms |
BCG 033; BCG-033
Click to Show/Hide
|
|||||
| Organization |
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 3 Indication(s)
Non-small cell lung cancer [ICD11:2C25]
Clinical candidate
Ovarian cancer [ICD11:2C73]
Clinical candidate
Triple negative breast cancer [ICD11:2C60-2C65]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Tumor-associated calcium signal transducer 2 (TACSTD2); Inactive tyrosine-protein kinase 7 (PTK7)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.